Terminated PHASE4 INTERVENTIONAL 2-arm NCT01286246

Randomized Controlled Trial of Vaginal Progesterone in Women With Threatened Preterm Labor (PROTO)

Pilot Randomized Controlled Trial of Vaginal Progesterone to Prevent Preterm Birth in Women With Threatened Preterm Labor

Sponsor: University of Calgary

Conditions Obstetric Labor, Premature

Interventions Placebo Vaginal progesterone

Updated 5 times since 2017 Last updated: Jan 7, 2015 Started: Jan 31, 2011 Primary completion: Oct 31, 2014 Completion: Oct 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Trial investigators were unable to recruit the estimated sample

Other terminated trials from University of Calgary

See all terminations from University of Calgary

Other Obstetric Labor, Premature trials with similar outcome

NCT01840228 · Phase NA · May 2018

Browse all Obstetric Labor, Premature trials

Listed as NCT01286246, this PHASE4 trial focuses on Obstetric Labor, Premature and remains terminated or withdrawn. Sponsored by University of Calgary, it has been updated 5 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Calgary

Data source: University of Calgary

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Calgary, Canada